PT  - JOURNAL ARTICLE
AU  - Ying Ying Leung
AU  - Ana-Maria Orbai
AU  - Alexis Ogdie
AU  - Laura C. Coates
AU  - Maarten de Wit
AU  - Kristina Callis Duffin
AU  - Lihi Eder
AU  - Dafna D. Gladman
AU  - Niti Goel
AU  - Philip J. Mease
AU  - Vibeke Strand
AU  - Oliver FitzGerald
AU  - William Tillett
TI  - The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set
AID  - 10.3899/jrheum.190122
DP  - 2019 Jun 01
TA  - The Journal of Rheumatology
PG  - 33--37
VI  - 95
4099  - http://www.jrheum.org/content/95/33.short
4100  - http://www.jrheum.org/content/95/33.full
SO  - J Rheumatol2019 Jun 01; 95
AB  - The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group reported at the 2018 GRAPPA annual meeting on the outcome of the OMERACT 2018 Conference in Terrigal, Australia. The working group presented the endorsement of the 66/68 joint count for the assessment of peripheral arthritis and the provisional endorsement of the PsA Impact of Disease 12 questionnaire for the assessment of PsA-specific health-related quality of life in PsA randomized controlled trials and observational studies. In this report, the group presents its plan to seek OMERACT endorsement for outcome measures that address the domains of MSK disease activity for enthesitis and dactylitis, physical function, fatigue, and structural damage following the OMERACT Filter 2.1 methodology.